Rami Doukky to Comorbidity
This is a "connection" page, showing publications Rami Doukky has written about Comorbidity.
Connection Strength
0.945
-
Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
Score: 0.129
-
Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging. J Nucl Med. 2016 Aug; 57(8):1251-7.
Score: 0.119
-
Impact of Diastolic Function Parameters on the Risk for Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation: A Prospective Study. J Am Soc Echocardiogr. 2016 06; 29(6):545-53.
Score: 0.118
-
Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2016 Jan 16; 14:4.
Score: 0.117
-
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.
Score: 0.115
-
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016 06; 23(3):560-9.
Score: 0.113
-
The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol. 2013 Oct; 20(5):774-84.
Score: 0.098
-
The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
Score: 0.094
-
Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
Score: 0.042